Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the action of GLP-1, a hormone that regulates appetite and blood sugar levels.
Semaglutide has made a significant impact on the weight loss journeys of many men and women. In a 68-week study, adults lost an average of 35 pounds, or 15% of their overall body weight, while taking Semaglutide (Lovelace Jr., 2023). Due to its effectiveness in reducing weight, it has become a preferred medication for those seeking help with weight management and aesthetic goals.
Conveniently, Semaglutide is administered as a once-a-week injection. It’s user-friendly and can be taken on any day that suits the individual best. Beyond the convenience of Semaglutide, weight reduction offers numerous benefits:
- Reducing the risk of heart disease, heart attack, and stroke.
- Lowering blood pressure.
- Improving mobility and reducing pain.
- Enhancing mood.
- Promoting better sleep.
- Boosting self-esteem.
- Lowering the risk for certain cancers.
Semaglutide is given through a subcutaneous injection once per week.
Reference:
Lovelace Jr., B. (2023). Experimental drug offers weight loss, now on the market, study finds. NBC News. https://www.nbcnews.com/health/health-news/experimental-drug-offer-weight-loss-drug-now-market-study-finds-rcna89702
First Dose Evaluation
Medical assessment and dosage triage
$150
1-Month Package
Most popular
First dose evaluation fee applied toward package enrollment
$500
2-Month Package
Preferred pricing
First dose evaluation fee applied toward package enrollment
$900
3-Month Package
Best value
First dose evaluation fee applied toward package enrollment
$1200
All monthly programs include clinically appropriate dosage escalation, provider follow-ups, standard titration protocols, and ongoing patient support.
